-
Company Profile
Global Blood Therapeutics Inc – Company Profile
Global Blood Therapeutics Inc (GBT), a subsidiary of Pfizer Inc, is a clinical-stage biopharmaceutical company. The company discovers and develops oxbryta (voxelotor), inclacumab and GBT601. Its products are used for the treatment of various therapeutic areas which includes sickle cell disease (SCD), chronic vaso-occlusive crisis (VOC) prevention, acute VOC re-admission prevention and hemolytic anemia. GBT offers products in tablet form for both children and adults under the brand name Oxbryta. The company also focuses on the development of therapies that...
Add to Basket -
Product Insights
Voc Training & Labor Prom Ofc – Dakhla City of Trades and Skills (CMC) – Dakhla-Oued Ed-Dahab
Equip yourself with the essential tools needed to make informed and profitable decisions with our Voc Training & Labor Prom Ofc - Dakhla City of Trades and Skills (CMC) - Dakhla-Oued Ed-Dahab report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our...
-
Company Profile
Advanced Micro-Fabrication Equipment Inc – Company Profile
Advanced Micro-Fabrication Equipment Inc.China (AMEC) is a micro-fabrication equipment company that researches, develops, manufactures and sells semiconductor equipment. The company offers etching equipment, MOCVD equipment and green facilities. Its etching equipment product technology range comprises CCP etch system, TSV etch system and VOC purification equipment. AMEC markets its products under Prismo HiT3, Primo HD-RIE and Primo SSC AD-RIE brand. Its product technology is used in the manufacturing of integrated circuits, light-emitting diode chip manufacturing and micro-electro-mechanical system. The company operates...
Add to Basket -
Company Profile
Ainos Inc – Company Profile
Ainos Inc (Ainos), formerly Amarillo Biosciences Inc, develops biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of diseases such as influenza, hepatitis C, thrombocytopenia, neoplastic, viral diseases, autoimmune disorders and other indications using its core technology (proprietary low dose form) of natural human interferon alpha. Its product portfolio includes COVID-19 point-of-care test such as antigen rapid test, molecular rapid test and VOC-based point-of-care. The company primarily operates in the US and...
Add to Basket -
Product Insights
Net Present Value Model: Adakveo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Adakveo Drug Details Crizanlizumab-TMCA (Adakveo, Chylotrez)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – rifaximin DR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry rifaximin DR Drug Details Rifaximin delayed-release formulation is under development for the treatment crohn's...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – sevuparin sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry sevuparin sodium Drug Details Sevuparin sodium (DF-02) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – crizanlizumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry crizanlizumab Drug Details Crizanlizumab-TMCA (Adakveo, Chylotrez) is a monoclonal antibody, produced by using recombinant...